» Articles » PMID: 36632785

Microbial Metabolite Dysbiosis and Colorectal Cancer

Overview
Journal Gut Liver
Specialty Gastroenterology
Date 2023 Jan 12
PMID 36632785
Authors
Affiliations
Soon will be listed here.
Abstract

The global burden of colorectal cancer (CRC) is expected to continuously increase. Through research performed in the past decades, the effects of various environmental factors on CRC development have been well identified. Diet, the gut microbiota and their metabolites are key environmental factors that profoundly affect CRC development. Major microbial metabolites with a relevance for CRC prevention and pathogenesis include dietary fiber-derived short-chain fatty acids, bile acid derivatives, indole metabolites, polyamines, trimethylamine-N-oxide, formate, and hydrogen sulfide. These metabolites regulate various cell types in the intestine, leading to an altered intestinal barrier, immunity, chronic inflammation, and tumorigenesis. The physical, chemical, and metabolic properties of these metabolites along with their distinct functions to trigger host receptors appear to largely determine their effects in regulating CRC development. In this review, we will discuss the current advances in our understanding of the major CRC-regulating microbial metabolites, focusing on their production and interactive effects on immune responses and tumorigenesis in the colon.

Citing Articles

Deciphering the metabolic landscape of colorectal cancer through the lens of AhR-mediated intestinal inflammation.

Swain J, Preeti , Mohanty C, Bajoria A, Patnaik S, Ward Gahlawat A Discov Oncol. 2025; 16(1):275.

PMID: 40053174 PMC: 11889322. DOI: 10.1007/s12672-025-01949-x.


Interactions between the tumor microbiota and breast cancer.

Guo H Front Cell Infect Microbiol. 2025; 14:1499203.

PMID: 39926112 PMC: 11802574. DOI: 10.3389/fcimb.2024.1499203.


Anaerobic spp. degrade sulfoquinovose via a bifurcated 6-deoxy-6-sulfofructose transketolase/transaldolase pathway to both C- and C-sulfonate intermediates.

Borusak S, Denger K, Dorendorf T, Fournier C, Lerner H, Mayans O Front Microbiol. 2024; 15:1491101.

PMID: 39712897 PMC: 11659671. DOI: 10.3389/fmicb.2024.1491101.


Exploring the gut microbiome's role in colorectal cancer: diagnostic and prognostic implications.

Chen G, Ren Q, Zhong Z, Li Q, Huang Z, Zhang C Front Immunol. 2024; 15:1431747.

PMID: 39483461 PMC: 11524876. DOI: 10.3389/fimmu.2024.1431747.


From colon wall to tumor niche: Unraveling the microbiome's role in colorectal cancer progression.

Garcia Menendez G, Sichel L, Lopez M, Hernandez Y, Arteaga E, Rodriguez M PLoS One. 2024; 19(10):e0311233.

PMID: 39436937 PMC: 11495602. DOI: 10.1371/journal.pone.0311233.


References
1.
Wyatt M, Greathouse K . Targeting Dietary and Microbial Tryptophan-Indole Metabolism as Therapeutic Approaches to Colon Cancer. Nutrients. 2021; 13(4). PMC: 8066279. DOI: 10.3390/nu13041189. View

2.
Windey K, De Preter V, Verbeke K . Relevance of protein fermentation to gut health. Mol Nutr Food Res. 2011; 56(1):184-96. DOI: 10.1002/mnfr.201100542. View

3.
Wiechers C, Zou M, Galvez E, Beckstette M, Ebel M, Strowig T . The microbiota is dispensable for the early stages of peripheral regulatory T cell induction within mesenteric lymph nodes. Cell Mol Immunol. 2021; 18(5):1211-1221. PMC: 8093251. DOI: 10.1038/s41423-021-00647-2. View

4.
Reddy B, Narisawa T, Wright P, Vukusich D, WEISBURGER J, Wynder E . Colon carcinogenesis with azoxymethane and dimethylhydrazine in germ-free rats. Cancer Res. 1975; 35(2):287-90. View

5.
Zheng X, Xie G, Zhao A, Zhao L, Yao C, Chiu N . The footprints of gut microbial-mammalian co-metabolism. J Proteome Res. 2011; 10(12):5512-22. DOI: 10.1021/pr2007945. View